Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer

Saved in:
Bibliographic Details
Published inTherapeutic advances in medical oncology Vol. 14; p. 17588359221142788
Main Authors Derks, Sarah, van Laarhoven, Hanneke W. M.
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.01.2022
Sage Publications Ltd
SAGE Publishing
Subjects
Chemotherapy
Esophageal cancer
Gastric cancer
Immunotherapy
Metastases
Monoclonal antibodies
Targeted cancer therapy
combination immunotherapy
gastric cancer
chemotherapy
oesophageal cancer
checkpoint inhibitor
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1758-8359
1758-8340
1758-8359
DOI:10.1177/17588359221142788